Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved multiple immune-related conditions in one patient.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

New treatments for lupus show promise, but more research is needed, especially for children.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

TAK-279 effectively reduces psoriasis symptoms and is safe.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Dupilumab may help treat hair loss and skin color loss in some patients with atopic dermatitis.